The US Senate’s recent proposal to reconsider taxing unrealized crypto gains is fueling a shift in the crypto landscape. With this potential change, investors are looking for tokens offering real-world utility and stability. This article examines three such projects: Qubetics, Injective, and Cosmos – these coins stand out as strong contenders for those seeking long-term value amidst regulatory uncertainty. How did the US Senate propose a major shift in crypto taxation? In a landmark move, U.S. Senators urged the Treasury Department to reconsider its stance on taxing unrealized crypto gains. This proposal, if implemented, would require investors to pay taxes on profits they haven’t even realized – a significant change that could impact how digital assets are viewed and managed. The rise of use-focused coins As this policy unfolds, there is a growing focus on tokens offering real functionality and clear roadmaps. Instead of chasing uncertain trends, community members are increasingly turning towards projects with demonstrable value and utility. Qubetics has emerged as a prime example of this trend. **Qubetics: Bridging the Gap Between Blockchains** Qubetics ($TICS) is tackling real-world problems by building interoperable solutions for fragmented blockchain ecosystems. Its Web3 aggregator seamlessly integrates networks like Ethereum, Solana, and Bitcoin into a single cohesive architecture. This eliminates data silos and isolated development protocols, enabling smoother access across chains and removing friction that has hampered mainstream adoption. The Qubetics presale: An Opportunity for Early Investors Qubetics’ presale is currently in stage 34, with the token price at $0.2532, a testament to its growing momentum. The project stands out because it prioritizes long-term vision and predictable growth. With a strict structure – each stage lasting only seven days ending every Sunday at midnight, followed by a guaranteed 10% price increase – this presale offers transparent projections and secure returns. **Injective: DeFi Infrastructure with Steady Growth Potential** Injective ($INjective) is experiencing strong user sentiment with a recent surge in price (5.48%) following the positive momentum of its DeFi infrastructure. This project, known for offering decentralized finance tools across multiple chains, continues to gain traction as its post-2025 growth projections are optimistic. Its focus on real-time trading experiences further adds to its appeal, particularly in a volatile market. **Cosmos: A Reliable Foundation in a Turbulent Market** Cosmos (ATOM) is quietly reclaiming market ground with its stable price and a renewed focus on long-term infrastructure. While not returning to earlier highs just yet, the community’s sentiment remains positive as Cosmos’ modular architecture has shown consistency in uncertain times. A Shift Towards Practical Solutions** The current regulatory environment adds urgency to crypto decisions. As these proposals unfold, there is a clear need for solutions that deliver real-world value and stability – a trend reflected by projects like Injective, Qubetics, and Cosmos. These three coins represent a shift away from speculative assets towards those offering tangible benefits for users and the broader blockchain landscape. **Key Takeaways** The current crypto market is undergoing a significant transformation driven by regulations and shifting investor preferences. This is leading to increased focus on tokens with real-world use cases and a clear roadmap, as demonstrated by Qubetics, Injective, and Cosmos. If you’re looking for long-term investment opportunities, these three projects offer a compelling case for early participation. For more information** Qubetics: https://qubetics.com Presale**: https://buy.qubetics.com/ Telegram**: https://t.me/qubetics ***Twitter**: https://x.com/qubetics **FAQs** Why is Qubetics considered one of the best coins to join now? It offers real utility through Web3 aggregation, solves major interoperability issues, and its ROI projections from the presale are unmatched in 2025. What’s different about the Qubetics presale compared to others? Each stage is seven days long with a guaranteed 10% price hike weekly, over $17M raised, and over 26,300 holders already involved. How is Injective performing in the current market? Injective is gaining traction with a recent 5.48% price increase and 63.41% of user sentiment rated as “Very Bullish.” Disclaimer: The text above is an advertorial article that is not part of bitcoininfonews.com editorial content.** **Please remember, all financial decisions should be made after conducting thorough research.**